ABEVMY is an antineoplastic drug used to treat;
brain tumours resistant to previous treatments
metastatic (spreading) cancer of the large bowel (i.e. in the colon or rectum), breast or cervix in combination with chemotherapy agents
lung cancer and cancer of the ovaries and fallopian tubes (which can extend to the lining of surrounding organs such as stomach, liver) in combination with chemotherapy agents
kidney cancer (renal cell cancer) in combination with interferon therapy.